Immunopathogenesis of hepatitis B. (Q35621639)

9 August 2017

1 reference

title

Immunopathogenesis of hepatitis B. (English)

1 reference

9 August 2017

Gabriele Missale

2

1 reference

ORCID Public Data File 2021

author name string

Carlo Ferrari

series ordinal

1

1 reference

PubMed ID

14708676

9 August 2017

Carolina Boni

series ordinal

3

1 reference

PubMed ID

14708676

9 August 2017

Simona Urbani

series ordinal

4

1 reference

9 August 2017

1 January 2003

1 reference

9 August 2017

Journal of Hepatology

1 reference

9 August 2017

39 Suppl 1

1 reference

9 August 2017

S36-42

1 reference

Noncytolytic control of viral infections by the innate and adaptive immune response

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Subversion of the immune system by pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Autoreactivity by design: innate B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Roles of alpha beta and gamma delta T cell subsets in viral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

T cell-dependent B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Molecular anatomy of viral persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Role of B cells in antigen presentation of the hepatitis B core

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

The serology of chronic hepatitis B infection revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Differential antigen-processing pathways of the hepatitis B virus e and core proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900137-5

7 January 2021

10.1016/S0168-8278(03)00137-5

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14708676